Discovery DMPK Services

Pharmaron’s DMPK services support the needs for preclinical candidate (PCC) identification and nomination, Investigational New Drug (IND) enabling and New Drug Application (NDA) packaging for regulatory submission.

Pharmaron’s DMPK group offers comprehensive in vitro ADME, in vitro toxicity and in vivo pharmacokinetics services, which allow for the evaluation of DMPK properties and toxicity of test articles with high data quality and in a cost-effective manner.

View our on-demand webinars within our DMPK series, covering a spectrum of interesting DMPK topics.

Download our flyer: Discovery DMPK

Capabilities

Discovery in vivo PK

Discovery in vitro ADMET

in vivo PK

Screening PK
Tissue distribution
Metabolism and excretion
in vivo PK models
Endogenous biomarkers

in vitro ADMET

Solution properties
Drug absorption and transport
Metabolic stability and metabolite identification
Drug-drug interactions
in vitro Toxicity

Explore Pharmaron’s DMPK webinar and podcast series library

DMPK Studies for R&D Efficiency

Learn how Pharmaron helps our partners improve their drug R&D efficiency.

scientist using Pepette Pro device

Related Services

Two researchers working on a lab task together

Learn more about Pharmaron’s biosciences services

Pharmaron’s in vitro biology, in vivo pharmacology, DMPK and discovery biologics services support drug discovery and early development programs. Integration of these functions, together with laboratory chemistry, CMC and safety assessment, successfully deliver preclinical candidates and IND packages.

Blue DNA Helix Molecule

Learn more about Pharmaron’s integrated drug discovery and development services

Pharmaron provides a complete integrated platform from drug discovery to proof of concept (“POC”). Our industry knowledge, strong execution tactics and end-to-end solutions shorten the drug discovery and development cycle.